Skip to main content
. Author manuscript; available in PMC: 2018 Jan 22.
Published in final edited form as: Bioorg Med Chem Lett. 2015 Apr 17;25(21):4950–4955. doi: 10.1016/j.bmcl.2015.04.036

Table 1.

Structures and biological activities of piperazine derivatives from Schemes 1 and 2

Compound number graphic file with name nihms932344t1.jpg graphic file with name nihms932344t2.jpg MAGI HIV1IIIB IC50a,b (μM) SDF-1 Ca2+ Flux CEM-1 IC50a (μM)
R1 R2 (*)-R/S
68a H H R 0.31 0.255
68b H H S 1.1 1.2
52a/b H Ph Mix. (1:1) 0.72 0.13
48a H CH2Ph R 0.15 0.23
48b H CH2Ph S 0.03 0.19
49a H C(O)Ph S 0.06 0.002
49b H C(O)Ph R 0.02 0.006
69a C(O)Ph H R >100
69b C(O)Ph H S >100
50a/b H graphic file with name nihms932344t3.jpg Mix. (2:1) 0.21
50b H R 0.15 0.035
53a H CO2CH2Ph S 0.34 0.018
53b H CO2CH2Ph R 1.35
51a H SO2Ph S 0.05 0.002
51b H SO2Ph R 0.02 0.023
54a H graphic file with name nihms932344t4.jpg S 4.6 0.071
55a H graphic file with name nihms932344t5.jpg S 3.44 0.039
56a H graphic file with name nihms932344t6.jpg S 0.05 0.002
57a H C(O)NHPh S 0.35 21
a

All assays were performed in duplicate.

b

The cytotoxicities (TC50’s) for all compounds were greater than 10 μM.